Skip to main content
Clinical Trials/NCT02670499
NCT02670499
Completed
Not Applicable

A Randomized Controlled Multicenter Study Comparing GAP-FLEX to Continuous Passive Motion (CPM) Therapy in Combination With Standard of Care Physical Therapy in Subjects With Total Knee Replacement (TKR)

Xeras Medical Technologies2 sites in 1 country28 target enrollmentStarted: November 18, 2015Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Xeras Medical Technologies
Enrollment
28
Locations
2
Primary Endpoint
Flexion

Overview

Brief Summary

Post Market TKR study

Detailed Description

A post-market study to evaluate the safety and effectiveness of the GAP-FLEX device in combination with standard of care physical therapy compared to the standard of care CPM device in combination with standard of care physical therapy in Subjects who have undergone TKR

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Minimum age 50 years
  • Subject is undergoing total knee replacement
  • Subject agrees to comply with the physical therapy regime

Exclusion Criteria

  • With a flexure contracture \> 10 degrees
  • Degree of flexion \< 60 degrees pre-procedure or immediately post-procedure
  • Severe motion restriction as determined by the investigator
  • Severe deformity determined by the investigator
  • Taking chronic pain medication for use other than knee pain
  • Post surgery hospital stay is \> 4 days
  • Knee disorders other than osteoarthritis
  • With fibromyalgia
  • Chronic narcotic use as determined by the investigator.
  • Have a medical or psychological history that in the opinion of the investigator would make the subject a poor candidate for the study.

Outcomes

Primary Outcomes

Flexion

Time Frame: Degree of flexion achieved at week 4 visit

improvement in week 4 visit degree of flexion measured by Goniometer in the GAP-FLEX group will be compared to the CPM

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Xeras Medical Technologies
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials